Yumeng Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yumeng Ding has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jinshan He
Cardiovascular Department, Peking University People’s Hospital, Beijing, China
1 shared publication - Sicong Li
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, China
1 shared publication - Xuebin Li
Peking University People’s Hospital, Beijing, China
1 shared publication - Yujia Tong
Institute of Medical Information, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 22 March 2022
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 2022, 1-23
Research Progress on Natural Products’ Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels
Antiarrhythmic drugs (AADs) have a therapeutic effect on atrial fibrillation (AF) by regulating the function of ion channels. However, several adverse effects and high recurrence rates after drug withdrawal seriously affect patients’ medication compliance and clinical prognosis. Thus, safer and more effective drugs are urgently needed. Active components extracted from natural products are potential choices for AF therapy. Natural products like Panax notoginseng (Burk.) F.H. Chen, Sophora flavescens Ait., Stephania tetrandra S. Moore., Pueraria lobata (Willd.) Ohwi var. thomsonii (Benth.) Vaniot der Maesen., and Coptis chinensis Franch. have a long history in the treatment of arrhythmia, myocardial infarction, stroke, and heart failure in China. Based on the classification of chemical structures, this article discussed the natural product components’ therapeutic effects on atrial fibrillation by regulating ion channels, connexins, and expression of related genes, in order to provide a reference for development of therapeutic drugs for atrial fibrillation.
- 22 March 2022
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 2022, 1-23
Open AccessResearch Progress on Natural Products’ Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels
Antiarrhythmic drugs (AADs) have a therapeutic effect on atrial fibrillation (AF) by regulating the function of ion channels. However, several adverse effects and high recurrence rates after drug withdrawal seriously affect patients’ medication compliance and clinical prognosis. Thus, safer and more effective drugs are urgently needed. Active components extracted from natural products are potential choices for AF therapy. Natural products like Panax notoginseng (Burk.) F.H. Chen, Sophora flavescens Ait., Stephania tetrandra S. Moore., Pueraria lobata (Willd.) Ohwi var. thomsonii (Benth.) Vaniot der Maesen., and Coptis chinensis Franch. have a long history in the treatment of arrhythmia, myocardial infarction, stroke, and heart failure in China. Based on the classification of chemical structures, this article discussed the natural product components’ therapeutic effects on atrial fibrillation by regulating ion channels, connexins, and expression of related genes, in order to provide a reference for development of therapeutic drugs for atrial fibrillation.